These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 4531839

  • 1. [Cardiotoxicity of rubidomycin. Anatomo-clinical study of 1 case].
    Fontaine JL, Bonnet-Gajdos M, Mougenot B.
    Arch Fr Pediatr; 1974; 31(7):697-704. PubMed ID: 4531839
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Polycardiographic evaluation of cardiotoxic effects of rubidomycin in patients with acute leukemia].
    Wodniecki J, Prochaczek F, Holowiecki J, Stella B.
    Acta Haematol Pol; 1976; 7(3):195-8. PubMed ID: 983667
    [Abstract] [Full Text] [Related]

  • 9. Erythroleukaemia and daunorubicin-induced cardiotoxicity in a young boy.
    Malhotra OP, Talwar KK, Chopra P, Kumar R.
    Br J Clin Pract; 1990 Dec; 44(12):633-4. PubMed ID: 2102164
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The effect of cytostatic therapy on hemodynamics (author's transl)].
    Schwingshackl H, Schwingshackl A, Dienstl F, Knapp E, Gmeiner R.
    Med Klin; 1974 Feb 15; 69(7):298-303. PubMed ID: 4522909
    [No Abstract] [Full Text] [Related]

  • 13. [Cardiac insufficiency caused by the use of daunorubicin. Clinical and developmental study of 4 recent cases].
    Bauters F, Plouvier B, Breviere G, Goudemand M.
    Sem Hop; 1975 Jun 14; 51(28):1949-57. PubMed ID: 180611
    [Abstract] [Full Text] [Related]

  • 14. Cardiac ultrastructural changes induced by daunorubicin therapy.
    Buja LM, Ferrans VJ, Mayer RJ, Roberts WC, Henderson ES.
    Cancer; 1973 Oct 14; 32(4):771-88. PubMed ID: 4270890
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA, Marcar JR, Schretlen ED.
    Padiatr Padol; 1971 Oct 14; 6(3):230-9. PubMed ID: 5293526
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Acute heart failure after a moderate dose of rubidomycin].
    Baledent M, Messerschmitt J, Bens JL, Quiret JC, Faille N.
    Sem Hop; 1972 Feb 08; 48(7):507-10. PubMed ID: 4338408
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Cardiac toxicity of rubidomycin. Apropos of 2 cases].
    Laine JL, Julienne O, Leroy J, Lamagnère JP, Laugier J, Desbuquois G.
    Pediatrie; 1973 Mar 08; 28(2):201-10. PubMed ID: 4725976
    [No Abstract] [Full Text] [Related]

  • 20. Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicity.
    Jones RL, Miles DW.
    Lancet Oncol; 2005 Feb 08; 6(2):67. PubMed ID: 15683815
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.